国家卫生健康委:发热门诊患者核酸检测争取4小时出结果

2020-07-02 佚名 国家卫生健康委官方网站

7月2日,国务院应对新型冠状病毒肺炎疫情联防联控机制综合组印发《关于进一步加快提高医疗机构新冠病毒核酸检测能力的通知》(以下简称《通知》)。《通知》称,为进一步提高医疗机构核酸检测能力,积极应对可能新

7月2日,国务院应对新型冠状病毒肺炎疫情联防联控机制综合组印发《关于进一步加快提高医疗机构新冠病毒核酸检测能力的通知》(以下简称《通知》)。《通知》称,为进一步提高医疗机构核酸检测能力,积极应对可能新出现的新冠肺炎疫情,满足疫情防控和复工复产检测需求,对各地提出具体工作要求。

一、要求高度重视提高核酸检测能力工作

各地和医疗机构要将提高核酸检测能力作为“外防输入、内防反弹”的基础性工作,加强核酸检测工作的规范管理,强化核酸检测能力储备,尽快提高检测能力,避免局部疫情出现甚至暴发时,医疗资源挤兑导致检测能力严重滞后,给疫情防控和群众健康带来不利影响。

二、加强当前核酸检测工作的规范管理

提高核酸检测的规范性和时效性。各地要统一新冠病毒核酸检测结果报告单格式,检测机构要通过自助打印、网络查询、快递邮寄等多种方式,为受检者出具检测报告。对于发热门诊患者的核酸检测,要在6小时内报告结果,争取缩短至4小时报告;对于普通门急诊、住院患者及陪护人员等人群的核酸检测,原则上要在12小时内报告结果;对于“愿检尽检”人群的核酸检测,一般在24小时内报告结果。

持续开展核酸检测培训。各地要大力开展新冠病毒核酸检测培训,按照《新型冠状病毒肺炎实验室检测技术指南》《新冠病毒核酸检测技术人员培训方案》等文件要求,加强标本采集、保存和运输、标本接收整理、核酸提取、试剂使用、荧光定量等检测方法、结果报告、生物安全等全流程培训。通过培训,确保各环节操作规范,进一步提高检测技术水平。

推动医疗机构互认检测结果。各地要结合本地疫情防控需要,制订区域内核酸检测结果互认的规定,明确互认的条件、有效期、医疗机构范围等,最大程度减少重复检测。各省级卫生健康行政部门要组织辖区内检测机构参加室间质评,保证每家机构每年至少参加1次室间质评。各医疗机构要加强实验室室内质控,常态化接受国家级或省级临床检验质量控制,保证检测质量。

三、做好核酸检测应对准备工作

掌握本地区核酸检测资源和能力现状。各地要全面掌握本地区医疗机构实验室现状,了解可用于新冠病毒核酸检测的医疗资源情况,要细化到每一家机构掌握其最大检测能力和实际检测量,包括综合医院、专科医院和医学检验实验室等医疗机构的核酸提取仪、荧光定量PCR仪、生物安全柜等仪器设备的型号、通量及功能状态等,检测技术人员以及防护物资等。对于新申请开展新冠病毒核酸检测的医疗机构实验室,各地卫生健康行政部门要抓紧组织审核验收,对符合条件的及时进行批准,增补到本地区核酸检测机构名单中,并向社会公布。

做好核酸检测能力储备并制订应急预案。各地在做好常态化疫情防控工作的同时,要未雨绸缪,为应对可能出现的聚集性疫情做好核酸检测能力储备,包括硬件储备、软件储备和人员储备等。县级以上卫生健康行政部门要分别组织制订提高核酸检测能力应急预案(以下简称应急预案),一旦出现疫情时,要根据需检测的“四类人员”数量,分梯度制订相应的应对措施,迅速调集资源,确保短时间内迅速提高检测能力。需要时,要加强省域内的检测资源调度,弥补局部地区可能存在的检测能力不足问题。本地区难以解决的,可按照程序向国务院联防联控机制提出需求。

全面加强医疗机构实验室能力建设。各地要加强三级综合医院、传染病专科医院的实验室建设,使其具备独立开展新冠病毒检测能力。加强其他二级以上医院、专科医院、医学检验实验室建设,使其逐步达到新冠病毒核酸检测条件。在县域内,要选择1家综合实力强的医疗机构予以支持,使县域内具备核酸检测能力。各医疗机构要根据每日发热门诊就诊人次、新入院患者数及其陪护人员数,结合普通门急诊就诊人次和“愿检尽检”人群,科学测算本机构应当达到的日检测能力。医疗机构要根据检测需求,认真做好实验室改造扩建、仪器设备配备、检测人员配置和培训、生物安全等相关工作。要按照《关于落实常态化疫情防控要求进一步加强医疗机构感染防控工作的通知》要求,强化新冠病毒核酸检测。对于急诊抢救患者,要在积极抢救的同时进行检测,不得因核酸检测影响紧急救治。

四、按时报送核酸检测信息

各医疗卫生机构落实好核酸检测日报告制度,为疫情防控提供重要参考,在信息报送过程中,保证数据安全等。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1932052, encodeId=8d87193205285, content=<a href='/topic/show?id=e7bd9e12736' target=_blank style='color:#2F92EE;'>#门诊患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97127, encryptionId=e7bd9e12736, topicName=门诊患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b191324, createdName=marongnuan, createdTime=Thu Sep 24 13:01:06 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770633, encodeId=b2301e706331c, content=<a href='/topic/show?id=5baa2e79055' target=_blank style='color:#2F92EE;'>#健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27790, encryptionId=5baa2e79055, topicName=健康委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d95e38178648, createdName=yyanpro@34cn.c, createdTime=Sun Feb 14 13:01:06 CST 2021, time=2021-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1458065, encodeId=997f1458065bf, content=<a href='/topic/show?id=61e236612ad' target=_blank style='color:#2F92EE;'>#卫生健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36612, encryptionId=61e236612ad, topicName=卫生健康委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a5a6003550, createdName=tidiq, createdTime=Sat Jul 04 13:01:06 CST 2020, time=2020-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469639, encodeId=fb3814696390a, content=<a href='/topic/show?id=d87a3e88924' target=_blank style='color:#2F92EE;'>#发热门诊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37889, encryptionId=d87a3e88924, topicName=发热门诊)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed9e7047232, createdName=zhenjiu125, createdTime=Sat Jul 04 13:01:06 CST 2020, time=2020-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493017, encodeId=676d149301e1d, content=<a href='/topic/show?id=d98f3660e57' target=_blank style='color:#2F92EE;'>#卫生健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36607, encryptionId=d98f3660e57, topicName=卫生健康)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60488981755, createdName=wangyang7961, createdTime=Sat Jul 04 13:01:06 CST 2020, time=2020-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568148, encodeId=8c3815681484f, content=<a href='/topic/show?id=85a54086193' target=_blank style='color:#2F92EE;'>#国家卫生健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40861, encryptionId=85a54086193, topicName=国家卫生健康委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b3515322450, createdName=xiaoshitou, createdTime=Sat Jul 04 13:01:06 CST 2020, time=2020-07-04, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1932052, encodeId=8d87193205285, content=<a href='/topic/show?id=e7bd9e12736' target=_blank style='color:#2F92EE;'>#门诊患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97127, encryptionId=e7bd9e12736, topicName=门诊患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b191324, createdName=marongnuan, createdTime=Thu Sep 24 13:01:06 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770633, encodeId=b2301e706331c, content=<a href='/topic/show?id=5baa2e79055' target=_blank style='color:#2F92EE;'>#健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27790, encryptionId=5baa2e79055, topicName=健康委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d95e38178648, createdName=yyanpro@34cn.c, createdTime=Sun Feb 14 13:01:06 CST 2021, time=2021-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1458065, encodeId=997f1458065bf, content=<a href='/topic/show?id=61e236612ad' target=_blank style='color:#2F92EE;'>#卫生健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36612, encryptionId=61e236612ad, topicName=卫生健康委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a5a6003550, createdName=tidiq, createdTime=Sat Jul 04 13:01:06 CST 2020, time=2020-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469639, encodeId=fb3814696390a, content=<a href='/topic/show?id=d87a3e88924' target=_blank style='color:#2F92EE;'>#发热门诊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37889, encryptionId=d87a3e88924, topicName=发热门诊)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed9e7047232, createdName=zhenjiu125, createdTime=Sat Jul 04 13:01:06 CST 2020, time=2020-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493017, encodeId=676d149301e1d, content=<a href='/topic/show?id=d98f3660e57' target=_blank style='color:#2F92EE;'>#卫生健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36607, encryptionId=d98f3660e57, topicName=卫生健康)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60488981755, createdName=wangyang7961, createdTime=Sat Jul 04 13:01:06 CST 2020, time=2020-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568148, encodeId=8c3815681484f, content=<a href='/topic/show?id=85a54086193' target=_blank style='color:#2F92EE;'>#国家卫生健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40861, encryptionId=85a54086193, topicName=国家卫生健康委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b3515322450, createdName=xiaoshitou, createdTime=Sat Jul 04 13:01:06 CST 2020, time=2020-07-04, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1932052, encodeId=8d87193205285, content=<a href='/topic/show?id=e7bd9e12736' target=_blank style='color:#2F92EE;'>#门诊患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97127, encryptionId=e7bd9e12736, topicName=门诊患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b191324, createdName=marongnuan, createdTime=Thu Sep 24 13:01:06 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770633, encodeId=b2301e706331c, content=<a href='/topic/show?id=5baa2e79055' target=_blank style='color:#2F92EE;'>#健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27790, encryptionId=5baa2e79055, topicName=健康委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d95e38178648, createdName=yyanpro@34cn.c, createdTime=Sun Feb 14 13:01:06 CST 2021, time=2021-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1458065, encodeId=997f1458065bf, content=<a href='/topic/show?id=61e236612ad' target=_blank style='color:#2F92EE;'>#卫生健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36612, encryptionId=61e236612ad, topicName=卫生健康委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a5a6003550, createdName=tidiq, createdTime=Sat Jul 04 13:01:06 CST 2020, time=2020-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469639, encodeId=fb3814696390a, content=<a href='/topic/show?id=d87a3e88924' target=_blank style='color:#2F92EE;'>#发热门诊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37889, encryptionId=d87a3e88924, topicName=发热门诊)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed9e7047232, createdName=zhenjiu125, createdTime=Sat Jul 04 13:01:06 CST 2020, time=2020-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493017, encodeId=676d149301e1d, content=<a href='/topic/show?id=d98f3660e57' target=_blank style='color:#2F92EE;'>#卫生健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36607, encryptionId=d98f3660e57, topicName=卫生健康)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60488981755, createdName=wangyang7961, createdTime=Sat Jul 04 13:01:06 CST 2020, time=2020-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568148, encodeId=8c3815681484f, content=<a href='/topic/show?id=85a54086193' target=_blank style='color:#2F92EE;'>#国家卫生健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40861, encryptionId=85a54086193, topicName=国家卫生健康委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b3515322450, createdName=xiaoshitou, createdTime=Sat Jul 04 13:01:06 CST 2020, time=2020-07-04, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1932052, encodeId=8d87193205285, content=<a href='/topic/show?id=e7bd9e12736' target=_blank style='color:#2F92EE;'>#门诊患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97127, encryptionId=e7bd9e12736, topicName=门诊患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b191324, createdName=marongnuan, createdTime=Thu Sep 24 13:01:06 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770633, encodeId=b2301e706331c, content=<a href='/topic/show?id=5baa2e79055' target=_blank style='color:#2F92EE;'>#健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27790, encryptionId=5baa2e79055, topicName=健康委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d95e38178648, createdName=yyanpro@34cn.c, createdTime=Sun Feb 14 13:01:06 CST 2021, time=2021-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1458065, encodeId=997f1458065bf, content=<a href='/topic/show?id=61e236612ad' target=_blank style='color:#2F92EE;'>#卫生健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36612, encryptionId=61e236612ad, topicName=卫生健康委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a5a6003550, createdName=tidiq, createdTime=Sat Jul 04 13:01:06 CST 2020, time=2020-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469639, encodeId=fb3814696390a, content=<a href='/topic/show?id=d87a3e88924' target=_blank style='color:#2F92EE;'>#发热门诊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37889, encryptionId=d87a3e88924, topicName=发热门诊)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed9e7047232, createdName=zhenjiu125, createdTime=Sat Jul 04 13:01:06 CST 2020, time=2020-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493017, encodeId=676d149301e1d, content=<a href='/topic/show?id=d98f3660e57' target=_blank style='color:#2F92EE;'>#卫生健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36607, encryptionId=d98f3660e57, topicName=卫生健康)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60488981755, createdName=wangyang7961, createdTime=Sat Jul 04 13:01:06 CST 2020, time=2020-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568148, encodeId=8c3815681484f, content=<a href='/topic/show?id=85a54086193' target=_blank style='color:#2F92EE;'>#国家卫生健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40861, encryptionId=85a54086193, topicName=国家卫生健康委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b3515322450, createdName=xiaoshitou, createdTime=Sat Jul 04 13:01:06 CST 2020, time=2020-07-04, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1932052, encodeId=8d87193205285, content=<a href='/topic/show?id=e7bd9e12736' target=_blank style='color:#2F92EE;'>#门诊患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97127, encryptionId=e7bd9e12736, topicName=门诊患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b191324, createdName=marongnuan, createdTime=Thu Sep 24 13:01:06 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770633, encodeId=b2301e706331c, content=<a href='/topic/show?id=5baa2e79055' target=_blank style='color:#2F92EE;'>#健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27790, encryptionId=5baa2e79055, topicName=健康委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d95e38178648, createdName=yyanpro@34cn.c, createdTime=Sun Feb 14 13:01:06 CST 2021, time=2021-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1458065, encodeId=997f1458065bf, content=<a href='/topic/show?id=61e236612ad' target=_blank style='color:#2F92EE;'>#卫生健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36612, encryptionId=61e236612ad, topicName=卫生健康委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a5a6003550, createdName=tidiq, createdTime=Sat Jul 04 13:01:06 CST 2020, time=2020-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469639, encodeId=fb3814696390a, content=<a href='/topic/show?id=d87a3e88924' target=_blank style='color:#2F92EE;'>#发热门诊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37889, encryptionId=d87a3e88924, topicName=发热门诊)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed9e7047232, createdName=zhenjiu125, createdTime=Sat Jul 04 13:01:06 CST 2020, time=2020-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493017, encodeId=676d149301e1d, content=<a href='/topic/show?id=d98f3660e57' target=_blank style='color:#2F92EE;'>#卫生健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36607, encryptionId=d98f3660e57, topicName=卫生健康)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60488981755, createdName=wangyang7961, createdTime=Sat Jul 04 13:01:06 CST 2020, time=2020-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568148, encodeId=8c3815681484f, content=<a href='/topic/show?id=85a54086193' target=_blank style='color:#2F92EE;'>#国家卫生健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40861, encryptionId=85a54086193, topicName=国家卫生健康委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b3515322450, createdName=xiaoshitou, createdTime=Sat Jul 04 13:01:06 CST 2020, time=2020-07-04, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1932052, encodeId=8d87193205285, content=<a href='/topic/show?id=e7bd9e12736' target=_blank style='color:#2F92EE;'>#门诊患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97127, encryptionId=e7bd9e12736, topicName=门诊患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b191324, createdName=marongnuan, createdTime=Thu Sep 24 13:01:06 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770633, encodeId=b2301e706331c, content=<a href='/topic/show?id=5baa2e79055' target=_blank style='color:#2F92EE;'>#健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27790, encryptionId=5baa2e79055, topicName=健康委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d95e38178648, createdName=yyanpro@34cn.c, createdTime=Sun Feb 14 13:01:06 CST 2021, time=2021-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1458065, encodeId=997f1458065bf, content=<a href='/topic/show?id=61e236612ad' target=_blank style='color:#2F92EE;'>#卫生健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36612, encryptionId=61e236612ad, topicName=卫生健康委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7a5a6003550, createdName=tidiq, createdTime=Sat Jul 04 13:01:06 CST 2020, time=2020-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469639, encodeId=fb3814696390a, content=<a href='/topic/show?id=d87a3e88924' target=_blank style='color:#2F92EE;'>#发热门诊#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37889, encryptionId=d87a3e88924, topicName=发热门诊)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed9e7047232, createdName=zhenjiu125, createdTime=Sat Jul 04 13:01:06 CST 2020, time=2020-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1493017, encodeId=676d149301e1d, content=<a href='/topic/show?id=d98f3660e57' target=_blank style='color:#2F92EE;'>#卫生健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36607, encryptionId=d98f3660e57, topicName=卫生健康)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60488981755, createdName=wangyang7961, createdTime=Sat Jul 04 13:01:06 CST 2020, time=2020-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1568148, encodeId=8c3815681484f, content=<a href='/topic/show?id=85a54086193' target=_blank style='color:#2F92EE;'>#国家卫生健康委#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=40861, encryptionId=85a54086193, topicName=国家卫生健康委)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b3515322450, createdName=xiaoshitou, createdTime=Sat Jul 04 13:01:06 CST 2020, time=2020-07-04, status=1, ipAttribution=)]

相关资讯

J Urol:局部前列腺癌高强度聚焦超声部分腺体消融的肿瘤和功能结果研究

最近,有研究人员回顾性的评估了高强度超声作为局部前列腺癌起始治疗手段的结果情况。研究人员进行了一个回顾性的多中心患者分析,这些患者在2013年1月和2017年9月之间经历了部分腺体切除研究总共包括了150名患者的166次手术。其中,89%的案例表现出等级2或者更高情况。跟踪调查的平均值为24.3 ± 14.4个月。前列腺特异性抗原均值从 7.9 ± 6.8 ng/ml下降到最低值2.7 ± 3.1

Biochemia Medica:临床医生对关键风险结果的意见:在克罗地亚一家三级医院的调查

如果每个实验室修改其关键结果报告实践程序,则以反映其患者群体的临床需求。

女子隆胸猝死手术台,两次死因鉴定结果不同

32岁的董女士在大连艺星医疗美容医院进行隆胸手术时,在手术台上呼吸、心跳骤停,抢救无效去世。北京青年报记者从死者家属处获悉,大连市卫健委委托司法鉴定机构对董女士的死亡原因进行了两次鉴定,第一次鉴定认为当事人符合因双肺脂肪栓塞伴过敏反应,继发DIC(弥散性血管内凝血)而死亡;在2019年12月20日的第二次鉴定结论中,认为董女士的死亡符合在手术过程中使用的麻醉药物作用所致。32岁女子隆胸呼吸骤停20

Int J Cardiol:主动脉瓣狭窄患者心肌梗死后双重抗血小板治疗的相关结果

由此可见,当采用DAPT治疗时,AS与MI后出血、复发性心肌梗死和死亡率风险增加有关。在这个高危人群中,可能需要个体化选择抗血小板治疗。

河北集采结果公示:硝苯地平1分2厘3,二甲双胍4分3……

仿制药价格出新低新一轮国家集采还未正式开始,多个仿制药已经再次刷新底价——硝苯地平(10mg)单片1分2厘3,尼群地平(10mg)单片1分9厘7,格列本脲片(2.5mg)单片1分9厘8。昨日(12月11日),河北省医用药品器械集中采购中心将拟中选的13种高血压糖尿病门诊药品进行公示。13个拟中选品种中,通过一致性评价的有4个品种5个品规,分别为卡托普利片、盐酸二甲双胍片、格列美脲片、阿卡波糖片。值

22个药,带量采购结果公布

药店集采,正在全面铺开。